Japer Therapeutics Warrants
JSPRW
16 hedge funds and large institutions have $3.71M invested in Japer Therapeutics Warrants in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 8 closing their positions.
21% more capital invested
Capital invested by funds: $3.07M → $3.71M (+$637K)
24% less funds holding
Funds holding: 21 → 16 (-5)
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ZA
Zazove Associates
Incline Village,
Nevada
|
+$134K |
| 2 |
Walleye Capital
New York
|
+$86.3K |
| 3 |
Walleye Trading
New York
|
+$43.7K |
| 4 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$25.5K |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$6.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$273K |
| 2 |
SRCM
Sage Rock Capital Management
New York
|
-$220K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$218K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$187K |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$101K |
JSPRW Hedge Fund Activity: Q3 2021 in Review
16 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q3 2021, worth a combined $3.71M — up 21% from $3.07M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of JSPRW and 3 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 2 added.
The largest buyer was Zazove Associates, opening a new position worth an estimated $134K. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $273K sold.
- 16 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q3 2021, down from 21 in Q2 2021.
- Funds reported $3.71M of Japer Therapeutics Warrants stock for Q3 2021, up 21% quarter-over-quarter.
- 3 funds opened new Japer Therapeutics Warrants positions in Q3 2021 and 8 closed out, a net change of -5 holders.
- The largest Japer Therapeutics Warrants buyer in Q3 2021 was Zazove Associates, an estimated $134K added.
- The largest Japer Therapeutics Warrants seller in Q3 2021 was P. Schoenfeld Asset Management (PSAM), an estimated $273K sold.
Based on aggregated 13F filings for Q3 2021.